Maria (Khalil) Chaudhry MD

PubMed

• 18 citations
  Single-agent belantamab mafodotin in patients with relapsed/refractory multiple myeloma: Final analysis of the DREAMM-2 trial.
  Ajay K Nooka, Adam D Cohen, Hans C Lee, Ashraf Badros, Attaya Suvannasankha
  Cancer. 2023-12-01
• 17 citations
  ASTCT Clinical Practice Recommendations for Transplantation and Cellular Therapies in Multiple Myeloma.
  Binod Dhakal, Nina Shah, Ankit Kansagra, Ambuj Kumar, Sagar Lonial
  Transplantation and Cellular Therapy. 2022-06-01
• 1 citations
  Incidence, Treatment, and Survival of Patients With T-Cell Lymphoma, T-Cell Large Granular Leukemia, and Concomitant Plasma Cell Dyscrasias.
  Zachary Braunstein, Eric McLaughlin, Miguel Ruiz, Lai Wei, Naresh Bumma
  Frontiers in Oncology. 2022-01-01

Abstracts/Posters

• Effect of Early Post Transplantation Tacrolimus Concentration on the Risk of Acute Graft-Versus-Host Disease in Allogenic Stem Cell Transplantation
  Maria Chaudhry, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Improvement in Survival of Multiple Myeloma Patients: A Long-Term Institutional Experience
  Maria Chaudhry, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• The Effect of Cytogenetic Abnormalities on Organ Involvement and Survival in Patients with AL Amyloidosis
  Maria Chaudhry, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• AL Amyloidosis: The Effects of Maintenance Therapy on Autologous Stem Cell Transplantation Outcomes
  Maria Chaudhry, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Join now to see all

Lectures

• Lenalidomide and Vorinostat Maintenance after Autologous Transplant in Multiple Myeloma- Long Term Follow-up 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Aryl Hydrocarbon Receptor (AHR) Antagonism As a Transformative, Dual-Mechanism Novel Therapy for Multiple Myeloma 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018